FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 11:00:17 13/05/2024 pm IST | ||
| 2.28 EUR | +7.04% |
|
| Current month | -52.46% | ||
| 1 month | -58.72% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/24/13 | 2.28 | +7.04% | 0 |
| 10/24/10 | 2.13 | +0.95% | 0 |
| 09/24/09 | 2.11 | -13.17% | 0 |
| 08/24/08 | 2.43 | -5.08% | 0 |
| 07/24/07 | 2.56 | +0.39% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 13, 2024 at 11:00 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UL8KPE |
| ISIN | DE000UL8KPE2 |
| Date issued | 16/10/2023 |
| Strike | 391.1 $ |
| Maturity | Unlimited |
| Parity | 33.35 : 1 |
| Emission price | 5.12 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.17 € |
|---|---|
| Lowest since issue | 1.65 € |
| Spread | 0.1 € |
| Spread % | 4.24% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat